CRISPR/Cas-based technologies have revolutionized genetic approaches to addressing a wide range of neurobiological questions. The ability of CRISPR/Cas to introduce mutations into target genes allows us to perform in vivo loss-of-function experiments without generating genetically engineered mice. However, the lack of a reliable method to determine genotypes of individual CRISPR/Cas-transfected cells has made it impossible to unambiguously identify the genetic cause of their phenotypes in vivo. Here, we report a strategy for single-cell genotyping in CRISPR/Cas-transfected neurons that were phenotypically characterized in vivo. We show that re-sectioning of cortical slices and subsequent laser microdissection allow us to isolate individual CRISPR/Cas-transfected neurons. Sequencing of PCR products containing a CRISPR/Cas-targeted genomic region in single reference neurons provided genotypes that completely correspond with those deduced from their target protein expression and phenotypes. Thus, our study establishes a powerful strategy to determine the causality between genotypes and phenotypes in CRISPR/Cas-transfected neurons.
You may also like
The fruit fly and its comb-shaped neurons
February 1, 2021Ernst Strüngmann Institute for Neuroscience
Science on film, episode 4: Motivational states of the...
January 29, 2021Max Planck Institute for Biological Cybernetics
A small molecule involved in depression
January 29, 2021Max Planck Institute of Psychiatry
Max Planck Florida and Zeiss Announce Research...
January 13, 2021Max Planck Florida Institute for Neuroscience
New approach reveals structure and function of...
December 16, 2020Max Planck Florida Institute for Neuroscience
Targeting Functionally Characterized Synaptic...
December 15, 2020Max Planck Florida Institute for Neuroscience